| |
|
|
|
|
|
| Home - Veterinary Companies - Europe - Poland - Vet-agro - Vetahepar Inj. |
Vetahepar Inj.
Veterinary pharmaceuticals |
 |
|
| Composition: |
10 solution of Menbutone
| | Description: |
Menbutone is a strong stimulant of secretion processes in the liver, pancreas, and glands of the alimentary tract mucosa. It increases secretion of bile, pancreas, and gastric juices by a factor of 2-5 in comparison to the physiological values. Indirectly
| | Indications: |
Dyspepsia, digestive disturbances and impaired secretion of the liver, pancreas, and glands of the alimentary tract mucosa. Supportive treatment of ketosis and in convalescence conditions.
| | Contra indications: |
Acute pancreatitis, acute hepatitis, obstruction of bile ducts (mechanical hepatitis), mechanical obstruction of the intestines (knots, cavities), cardiac failure
| | Side effects: |
Transitional excitation of the peristalsis of the alimentary tract, excess salivation, increased sweating, eye tearing, increased urine excretion, dark colour of the faeces. Light pain may occur in the injection site, subject to spontaneous relief after a
| | Dosage: |
The recommended dose for administration in big animals is 5-10 mg menbutone per 1 kg b.w., corresponding to 1 ml preparation per 10-20 kg b.w. VETAHEPAR is administered intramuscularly via deep injection or intravenously, dependent on the animal species,
| | Withdrawal times: |
Edible tissues- 3 days
Milk - 1 day
| | Packing: |
100 ml PET bottles
|
|
|
|
Members in: Albania, Armenia, Austria, Azerbaijan, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Georgia, Germany, Gibraltar, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Macedonia, Malta, Moldova,Republic of, Netherlands (Holland), Norway, Poland, Portugal, Romania, Russian Federation, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey, Ukraine, United Kingdom, Uzbekistan, Yugoslavia
|
| Copyright (c) 2003-2007 - Business Portals BV |
